Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC1A2 | P43004 | 2/20 | 0.53 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.53 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.53 |
| ▸ | DDAH1 | O94760 | 3/20 | 0.49 |
| ▸ | NOS1 | P29475 | 5/20 | 0.47 |
| ▸ | NOS3 | P29474 | 3/20 | 0.47 |
| ▸ | NOS2 | P35228 | 2/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | THPO | P40225 | 1/20 | 0.47 |
| ▸ | BHMT | Q93088 | 6/20 | 0.47 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.47 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.47 |
| ▸ | BHMT2 | Q9H2M3 | 1/20 | 0.47 |
| ▸ | GSR | P00390 | 1/20 | 0.47 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Norleucine SCHEMBL4068645 | 1.00 | SLC1A2 (0.53) | SLC1A2SLC1A1SLC1A3DDAH1NOS1 | |
| Norleucine SCHEMBL12485005 | 0.96 | SLC1A2 (0.50) | SLC1A2SLC1A1SLC1A3DDAH1NOS1 | |
| Norleucine SCHEMBL12485007 | 0.96 | SLC1A2 (0.50) | SLC1A2SLC1A1SLC1A3DDAH1NOS1 | |
| Racemethionine SCHEMBL8714479 | 0.90 | BHMT (0.52) | SLC1A2SLC1A1SLC1A3NOS1NOS3 | |
| Racemethionine SCHEMBL11179574 | 0.89 | BHMT (0.50) | SLC1A2SLC1A1SLC1A3NOS1NOS3 | |
| Methionine SCHEMBL11179579 | 0.89 | BHMT (0.50) | SLC1A2SLC1A1SLC1A3NOS1NOS3 | |
| Racemethionine SCHEMBL23361954 | 0.88 | BHMT (0.57) | SLC1A2SLC1A1SLC1A3NOS1NOS3 | |
| Racemethionine SCHEMBL126688 | 0.88 | — | — | |
| Racemethionine SCHEMBL8983115 | 0.88 | BHMT (0.57) | SLC1A2SLC1A1SLC1A3NOS1NOS3 | |
| Methionine SCHEMBL5584463 | 0.88 | BHMT (0.57) | SLC1A2SLC1A1SLC1A3NOS1NOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0226304-B1 | COMPOSITION CONTAINING A PENEM OR CARBAPENEM ANTIBIOTIC | SANKYO COMPANY LIMITED (JP) | 1991-08-28 | — | — | EP | claimed |
| EP-0226304-A1 | Composition containing a penem or carbapenem antibiotic | SANKYO COMPANY LIMITED (JP) | 1987-06-24 | — | — | EP | claimed |
| EP-2032701-A1 | POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN CANCER | Alethia Biotherapeutics Inc. (CA) | 2009-03-11 | — | — | EP | disclosed |
| WO-2007147265-A1 | POLYNUCLEOTIDES AND POLYPEPTIDE SEQUENCES INVOLVED IN CANCER | ALETHIA BIOTHERAPEUTICS INC. (CA) | 2007-12-27 | — | — | WO | disclosed |
| EP-1356279-A2 | WATER-SOLUBLE, FLUORESCENT, & ELECTROPHORETICALLY MOBILE PEPTIDIC SUBSTRATES FOR ENZYMATIC REACTIONS AND METHODS FOR THEIR USE IN HIGH-THROUGHPUT SCREENING ASSAYS | NANOGEN (US) | 2003-10-29 | — | — | EP | disclosed |
| WO-2002061114-A9 | WATER-SOLUBLE, FLUORESCENT AND MOBILE PEPTIDE SUBSTRATES | NANOGEN INC (US) | 2003-08-07 | — | — | WO | disclosed |
| WO-2002061114-A2 | WATER-SOLUBLE, FLUORESCENT AND MOBILE PEPTIDE SUBSTRATES | NANOGEN, INC. (US) | 2002-08-08 | — | — | WO | disclosed |
| EP-0288087-B1 | Method for producing protein containing nonprotein amino acids | WAKUNAGA SEIYAKU KK (JP) | 1995-02-22 | — | — | EP | disclosed |
| US-4879223-A | Method for producing protein containing nonprotein amino acids | WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) | 1989-11-07 | — | — | US | disclosed |
| EP-0288087-A2 | Method for producing protein containing nonprotein amino acids | WAKUNAGA SEIYAKU KABUSHIKI KAISHA (JP) | 1988-10-26 | — | — | EP | disclosed |